Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Mar 2012 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Gold history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Aditya Birla Sun Life Gold Fund |
|---|---|
| 22 Mar 2012 | ₹100.00 |
| 04 Jun 2013 | ₹93.72 |
| 16 Aug 2014 | ₹96.49 |
| 29 Oct 2015 | ₹84.68 |
| 10 Jan 2017 | ₹95.96 |
| 24 Mar 2018 | ₹98.25 |
| 06 Jun 2019 | ₹103.45 |
| 18 Aug 2020 | ₹166.67 |
| 30 Oct 2021 | ₹147.54 |
| 12 Jan 2023 | ₹168.97 |
| 26 Mar 2024 | ₹197.57 |
| 07 Jun 2025 | ₹284.46 |
| 20 Aug 2026 | ₹450.30 |
| Metric | Aditya Birla Sun Life · Regular NAV ₹45.01 High risk ★★★☆☆ | Category median FoF Domestic · 148 funds |
|---|---|---|
| +56.55% | +7.03% | |
| +36.80% | +13.88% | |
| +25.31% | +11.19% | |
| +15.78% | +11.61% | |
| +11.01% | +10.54% | |
| +32.27% | — | |
| +9.81% | +12.35% | |
| +9.44% | +10.37% | |
| +9.31% | +8.94% | |
| Risk | ||
| 22.20% | 15.84% | |
| 1.36 | 0.70 | |
| 1.98 | 0.97 | |
| -29.33% | -19.67% | |
| Gold | — | |
| -2.25% | +1.35% | |
| 1.07 | 0.94 | |
| 99.2% | 97.2% | |
| 102.2% | 93.6% | |
| 0.52% | 0.58% | |
| ₹1,754Cr | ₹226.32Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 10% | |
| Priya Sridhar · 1.6y | — | |
| 22 Mar 2012 | — | |
| — | — | |
| — | — | |
| -0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.